Stress, allostatic load, catecholamines, and other neurotransmitters in neurodegenerative diseases

Endocrine Regulations

Volumn 45, Issue 2, 2011, Pages 91-98

  Goldstein, D S ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Allostasis; Catecholamines; Homeostasis; Parkinson disease; Stress

Indexed keywords

CATECHOLAMINE; NEUROTRANSMITTER; SYNUCLEIN;

ALLOSTASIS; ARTICLE; AUTONOMIC DYSFUNCTION; AUTOTOMY; CATECHOLAMINE NERVE CELL; CELL STRESS; DIFFUSE LEWY BODY DISEASE; HOMEOSTASIS; HUMAN; PARKINSON DISEASE; PATHOGENESIS; STRESS;

AGED; ALLOSTASIS; ALPHA-SYNUCLEIN; CATECHOLAMINES; HOMEOSTASIS; HUMANS; LEWY BODIES; NEURODEGENERATIVE DISEASES; NEURONS; NEUROTRANSMITTER AGENTS; PARKINSON DISEASE; STRESS, PHYSIOLOGICAL;

EID: 79961075094     PISSN: 12100668     EISSN: 13360329     Source Type: Journal    
DOI: 10.4149/endo_2011_02_91     Document Type: Article

References (19)

1. Burke WJ, Kumar VB, Pandey N, Panneton WM, Gan Q, Franko MW, O'Dell M, Li SW, Pan Y, Chung HD, Galvin JE: Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine. Acta Neuropathol 115, 193-203, 2008. doi:10.1007/s00401-007-0303-9
2. Creveling CR: The Role of Catechol Quinone Species in Cellular Toxicity. FP Graham Publishing Co., Johnson City, TN 2000.
3. Ehringer H, Hornykiewicz O: [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system.]. Wien Klin Wochenschr 38, 1236-1239, 1960.
4. Eisenhofer G, Kopin IJ, Goldstein DS: Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56, 331-349, 2004a. doi:10.1124/pr.56.3.1
5. Eisenhofer G, Kopin IJ, Goldstein DS: Leaky catecholamine stores: undue waste or a stress response coping mechanism? Ann N Y Acad Sci 1018, 224-230, 2004b. doi:10.1196/annals.1296.027
6. Goldstein DS: Adrenaline and the Inner World: An Introduction to Scientific Integrative Medicine. The Johns Hopkins University Press, Baltimore, MD 2006.
7. Goldstein DS, Li ST, Kopin IJ: Sympathetic neurocirculatory failure in Parkinson disease: Evidence for an etiologic role of alpha-synuclein. Ann Intern Med 135, 1010-1011, 2001.
8. Goldstein DS, Sullivan P, Holmes C, Kopin IJ, Basile MJ, Mash DC: Catechols in post-mortem brain of patients with Parkinson disease. Eur J Neurol (in press), Graboys T: Life in the Balance. New York: Sterling, New York 2008.
9. Jinsmaa Y, Florang VR, Rees JN, Anderson DG, Strack S, Doorn JA: Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate. Chem Res Toxicol 22, 835-841, 2009. doi:10.1021/tx800405v
10. Kaufmann H, Biaggioni I: Autonomic failure in neurodegenerative disorders. Semin Neurol 23, 351-363, 2003. doi:10.1055/s-2004-817719
11. Lee H, Dellatore SM, Miller WM, Messersmith PB: Mussel-inspired surface chemistry for multifunctional coatings. Science 318, 426-430, 2007. doi:10.1126/science.1147241
12. Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, Schmitz Y, Krantz DE, Kobayashi K, Edwards RH, Sulzer D: Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62, 218-229, 2009. doi:10.1016/j.neuron.2009.01.033
13. Mosharov EV, Staal RG, Bove J, Prou D, Hananiya A, Markov D, Poulsen N, Larsen KE, Moore CM, Troyer MD, Edwards RH, Przedborski S, Sulzer D: Alpha-synuclein overexpression increases cytosolic catecholamine concentration. J Neurosci 26, 9304-9311, 2006. doi:10.1523/JNEUROSCI.0519-06.2006
14. Panneton WM, Kumar VB, Gan Q, Burke WJ, Galvin JE: The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis. PLoS One 5, e15251, 2010. doi:10.1371/journal.pone.0015251
15. Park SS, Schulz EM, Lee D: Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein. Eur J Neurosci 26, 3104-3112, 2007. doi:10.1111/j.1460-9568.2007.05929.x
16. Rees JN, Florang VR, Eckert LL, Doorn JA: Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol. Chem Res Toxicol 22, 1256-1263, 2009. doi:10.1021/tx9000557
17. Sharabi Y, Imrich R, Holmes C, Pechnik S, Goldstein DS: Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension. Mov Disord 23, 1725-1732, 2008. doi:10.1002/mds.22226
18. Singleton A, Gwinn-Hardy K, Sharabi Y, Li ST, Holmes C, Dendi R, Hardy J, Crawley A, Goldstein DS: Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain 127, 768-772, 2004. doi:10.1093/brain/awh081
19. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M: Alpha-synuclein in Lewy bodies. Nature 388, 839-840, 1997. doi:10.1038/42166